Last updated: January 2026
By accessing or using Insivio’s platform and services, you agree to be bound by these Terms of Service. If you do not agree to these terms, please do not use our services.
Insivio provides AI-powered health technology and computational drug discovery tools. Our services include LongeviTwin (an AI health digital twin platform) and a Drug Discovery platform for researchers. Services are provided for informational and research purposes only.
To access our services, you must create an account with accurate and complete information. You are responsible for maintaining the confidentiality of your account credentials and for all activities that occur under your account.
You agree not to:
Pilot Stage: Insivio is currently in pilot stage. Features, functionality, and availability may change without notice as we continue to develop and improve our platform.
AI Limitations: Our platform uses artificial intelligence to generate predictions and analyses. AI systems can make errors. All outputs should be reviewed critically and verified through appropriate means.
Not Medical Advice: LongeviTwin and our health tools provide informational insights only and are not a substitute for professional medical advice, diagnosis, or treatment. Always consult qualified healthcare professionals for medical decisions.
Research Use Only: Our drug discovery tools provide computational predictions for research purposes only and are not intended for clinical use without appropriate validation and regulatory approval.
To the maximum extent permitted by law, Insivio shall not be liable for any indirect, incidental, special, consequential, or punitive damages arising from your use of our services. Our total liability shall not exceed the amounts paid by you to Insivio in the twelve months preceding the claim.
We reserve the right to modify these Terms of Service at any time. We will notify users of significant changes via email or through the platform. Continued use of our services after changes constitutes acceptance of the updated terms.